Skip to main content
Informational

Data use:

We use cookies and similar tools to make your use of this website easy and to keep it working properly. We may share data about you and how you use the site with third parties, such as analytics and marketing partners. Learn more in our Privacy Policy and Terms of Use. By continuing to use the site, you agree to this.

RxOutlook®

The latest pipeline drug information, trend news, upcoming drug launches and emerging therapies in today’s pharmaceutical market.

1st Quarter 2024

Key topics in this quarter’s edition include:

  • Fidanacogene elaparvovec (gene therapy) for treatment of hemophilia B 
  • mRNA-1345 vaccine for RSV infection
  • Ensifentrine for treatment of chronic obstructive pulmonary disease (COPD)

Download PDF